Cargando…
Hepatitis B reactivation in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
BACKGROUND: Immunotherapy shows promise as a treatment option for various cancers. However, there is growing concern over potential complications from hepatitis B virus (HBV) reactivation after checkpoint blockade immunotherapy. Although most of the previous clinical trials on immune checkpoint inhi...
Autores principales: | Xia, Zhengzheng, Zhang, Jianyu, Chen, Wenjun, Zhou, Haiyan, Du, Di, Zhu, Kongcai, Chen, Hui, Meng, Jun, Yang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515058/ https://www.ncbi.nlm.nih.gov/pubmed/37736699 http://dx.doi.org/10.1186/s40249-023-01128-6 |
Ejemplares similares
-
Seroprevalence of hepatitis E in adults in Brazil: a systematic review and meta-analysis
por: Tengan, Fátima Mitiko, et al.
Publicado: (2019) -
The effect of proton pump inhibitor uses on outcomes for cancer patients treated with immune checkpoint inhibitors: a meta-analysis
por: Li, Chao, et al.
Publicado: (2020) -
Gender development and hepatitis B and C infections among pregnant women in Africa: a systematic review and meta-analysis
por: Bigna, Jean Joel, et al.
Publicado: (2019) -
The incubation period of COVID-19: a global meta-analysis of 53 studies and a Chinese observation study of 11 545 patients
por: Cheng, Cheng, et al.
Publicado: (2021) -
The global and regional prevalence of hepatitis C and B co-infections among prisoners living with HIV: a systematic review and meta-analysis
por: Ahmadi Gharaei, Hasan, et al.
Publicado: (2021)